Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature Medicine
HONG KONG, Jan. 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine published the results of the company's independently developed PD-1/CTLA-4...
Greater Insurability of Climate Risk is Key to Global Economic Resilience: Aon Catastrophe Report
Annual report reveals 60 percent of economic damage caused by catastrophes in 2024 was uninsured Insured losses reached $145 billion globally – the sixth costliest year on record DUBLIN, Jan. 22, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading...
The BioCircular Materials Alliance initiated by Spiber welcomes new partners including Stella McCartney and publishes its first Progress Report
Stella McCartney, Marzotto Wool Manufacturing Srl, Fashion for Good, and 13 new companies and organizations have joined the BioCircular Materials Alliance (the "Alliance"), led by biomaterials pioneer Spiber. The Alliance published its first...
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers PLYMOUTH MEETING, Pa., Jan. 16, 2025 /PRNewswire/ -- Today, the National...
Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
YANTAI, China, Jan. 8, 2025 /PRNewswire/ -- On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a top oncology journal globally, published remarkable long-term follow-up results of a phase 1b/2 clinical trial on Disitamab Vedotin (DV) (developed...
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine
BEIJING, SHANGHAI and BOSTON, Jan. 7, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed...
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx...
Grand design highlights Macao's achievements
BEIJING, Dec. 20, 2024 /PRNewswire/ -- A news report from China Daily: In celebration of the 25th anniversary of Macao's return to the motherland, English-language newspaper China Daily has published a special data page on Friday. In celebration of...
Xinhua Silk Road: Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness published in Beijing on Wed.
BEIJING, Dec. 18, 2024 /PRNewswire/ -- The Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) was released at the 2024 Beijing Forum on Swift Response to Public Complaints held in Beijing on Wednesday. Photo...
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 13, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute for Business Value today published its latest 'Automotive 2035' study which reveals an industry grappling with an erratic transition away from current products and business...